Florida 2025 Regular Session

Florida House Bill H0149 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2
3	3	HB 149 2025
4	4
5	5
6	6
7	7	CODING: Words stricken are deletions; words underlined are additions.
8	8	hb149-00
9	9	Page 1 of 3
10	10	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
11	11
12	12
13	13
14	14	A bill to be entitled 1
15	15	An act relating to claims for adverse reactions to 2
16	16	vaccines and drugs under the Medicaid and medically 3
17	17	needy programs; providing a short title; creating s. 4
18	18	409.9043, F.S.; requiring the Agency for Health Care 5
19	19	Administration to expedite the review and payment 6
20	20	process for claims related to adverse reactions to 7
21	21	vaccines, immunizing agents, and emergency 8
22	22	countermeasure drugs under the Medicaid and Florida 9
23	23	Medicaid medically needy programs; requiring the 10
24	24	agency to publish certain information on its website; 11
25	25	requiring the agency to seek federal approval for a 12
26	26	specified purpose under certain circumstances and to 13
27	27	adopt rules; providing an effective date. 14
28	28	15
29	29	Be It Enacted by the Legislature of the State of Florida: 16
30	30	17
31	31	Section 1. This act may be cited as the "Cody's Law: 18
32	32	Florida No Vaccine-Injured Patient Left Behind." 19
33	33	Section 2. Section 409.9043, Florida Statutes, is created 20
34	34	to read: 21
35	35	409.9043 Claims for advers e reactions to vaccines, 22
36	36	immunizing agents, and emergency countermeasure drugs under the 23
37	37	Medicaid and medically needy programs. — 24
38	38	(1) The Agency for Health Care Administration shall, under 25
39	39
40	40	HB 149 2025
41	41
42	42
43	43
44	44	CODING: Words stricken are deletions; words underlined are additions.
45	45	hb149-00
46	46	Page 2 of 3
47	47	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
48	48
49	49
50	50
51	51	the Medicaid program and the Florida Medicaid medically needy 26
52	52	program, expedite the review and payment process for a claim in 27
53	53	which the physician has diagnosed a severe, debilitating, life -28
54	54	threatening, or lifelong injury caused by the administration of 29
55	55	a vaccine or other immunizing agent or an adverse reaction to an 30
56	56	emergency countermeasure drug if the vaccine, immunizing agent, 31
57	57	or emergency countermeasure drug is recommended by the United 32
58	58	States Food and Drug Administration or the Department of Health 33
59	59	of this state. 34
60	60	(2)(a) The agency shall publish on its website: 35
61	61	1. A list of medical conditions related to a vaccine, 36
62	62	immunizing agent, or emergency countermeasure drug for the 37
63	63	expedited claims described in subsection (1). 38
64	64	2. A list of potential adverse reactions found in the 39
65	65	manufacturer's product insert of a vaccine, immunizing agent, or 40
66	66	drug which are deemed critical, severe, or temporarily or 41
67	67	permanently disabling by the agency or the physicians who make 42
68	68	the diagnoses in the claims described in subsection (1). 43
69	69	3. Any new medical condition related to a vaccine, 44
70	70	immunizing agent, or emergency countermeasure drug which arises. 45
71	71	4. Any future vaccine, immunizing agent, or emergency 46
72	72	countermeasure drug or treatment deemed appropriate by the 47
73	73	agency or by the physicians who make the diagnoses in the claims 48
74	74	described in subsection (1). 49
75	75	(b) The agency shall also inform its website visitors of 50
76	76
77	77	HB 149 2025
78	78
79	79
80	80
81	81	CODING: Words stricken are deletions; words underlined are additions.
82	82	hb149-00
83	83	Page 3 of 3
84	84	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
85	85
86	86
87	87
88	88	the content of this section, including the requirements under 51
89	89	subsection (1), so that physicians or other health care 52
90	90	providers may best serve patients who have urgent medical needs 53
91	91	as a result of an injury caused by the administration of a 54
92	92	vaccine or other immunizing agent or an adverse reaction to an 55
93	93	emergency countermeasure drug. 56
94	94	(3) The agency shall seek federal approval, if necessary, 57
95	95	to implement this section and shall adopt ru les to administer 58
96	96	this section. 59
97	97	Section 3. This act shall take effect July 1, 2025. 60